Two pharma companies, but different stories. That's the picture Sun Pharma and Aurobindo Pharma's quarterly numbers have painted.And the reaction from the Street has been fitting.
Traders cheered Aurobindo's in-line performance by sending the stock nearly 4 percent higher. But they punished Sun Pharma for missing Street estimates across the board by sending the stock down over 6 percent.
CNBC-TV18's Ekta Batra and Archana Shukla crunch the numbers.Watch the video for more
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
